A new stable GIP-Oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus

International audience

Long-term consequences of Hodgkin lymphoma therapy on T-cell lymphopoiesis

International audience